Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $15.8000 (0.57%) ($15.8000 - $15.8000) on Thu. Oct. 21, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.02% (three month average) | RSI | 38 | Latest Price | $15.8000(0.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.1% a day on average for past five trading days. | Weekly Trend | ATRA declines -6.4% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) IBB(46%) ARKG(45%) ARKK(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.51% in a week (0% probabilities). VIXM(-40%) VXX(-28%) UNG(-16%) USO(-11%) TLT(-11%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.51% (StdDev 3.02%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $4.18(-73.54%) | Resistance Level | $16.68 | 5 Day Moving Average | $15.3(3.27%) | 10 Day Moving Average | $15.95(-0.94%) | 20 Day Moving Average | $16.68(-5.28%) | To recent high | -11.9% | To recent low | 31.6% | Market Cap | $1.174b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |